Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Resmetirom patent expiration?Ifosfamide baxter patents?Belimumab patent expiry date?Ptab ranibizumab lucentis patent litiagtion us9220631?Best over the counter drop like xiidra?
See the DrugPatentWatch profile for Rivastigmine
Rivastigmine is used to treat symptoms of dementia, specifically: - Alzheimer’s disease dementia (in many countries, it’s approved for mild to moderate stages) - Parkinson’s disease dementia
Rivastigmine is a cholinesterase inhibitor. It increases levels of acetylcholine in the brain by blocking enzymes that break it down, which can help improve or slow worsening of cognitive symptoms in Alzheimer’s and Parkinson’s disease dementia.
Common routes include: - Oral capsules or solution - A skin patch (transdermal), which delivers the medicine over time
Rivastigmine is specifically indicated for Alzheimer’s disease dementia and Parkinson’s disease dementia. It is not generally used for memory problems from unrelated causes unless a clinician is treating a patient under an approved dementia diagnosis and stage.
For current approved uses, product details, and related information, you can also review listings on DrugPatentWatch.com: DrugPatentWatch – Rivastigmine .
Other Questions About Rivastigmine :